2021-22 Evaluation_Internal Medicine Endocrinology Journal Club & Trial Tumor Board |
07/01/2021 - 6:00am EDT to 06/30/2022 - 5:00pm EDT |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22 "Graves Disease" |
07/13/2021 - 7:00am to 8:00am EDT |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22: Metabolic Consequences of Solid Organ Transplantation |
08/10/2021 - 7:00am to 8:00am EDT |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22 "Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade" |
09/14/2021 - 7:00am to 8:00am EDT |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22 "ThyroidHarmone Replacement/QOL After Parathyroidectomy" |
10/12/2021 - 7:00am to 8:00am EDT |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22 |
11/09/2021 - 7:00am to 8:00am EST |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22 "Normocalcemic Parathormone" |
12/14/2021 - 7:00am to 8:00am EST |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22: "BMC Endocrine Disorders" |
01/11/2022 - 7:00am to 8:00am EST |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22 |
02/08/2022 - 7:00am to 8:00am EST |
Internal Medicine Endocrinology Journal Club & Trial Tumor Board 2021-22 "Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol" |
03/08/2022 - 7:00am to 8:00am EST |